Sign in
4

Changes in Ownership

VERACYTE, INC. Filed Acc 0001649245-26-000009

Chief Scientific & Med Officer sold 13,110 shares at an average $43.05 ($564,410)

  • Chief Scientific & Med Officer gave up 3,639 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Febbo Phillip G. Chief Scientific & Med Officer 2026-09-02 Shares withheld for taxes 10b5-1 −3,639 $44.88 $163,318 146,158 D: show line 1 in the form
Febbo Phillip G. Chief Scientific & Med Officer 2026-09-04 Sale 10b5-1 −10,405 $42.89 $446,305 135,753 D: show line 2 in the form
Febbo Phillip G. Chief Scientific & Med Officer 2026-09-04 Sale 10b5-1 −2,705 $43.66 $118,105 133,048 D: show line 3 in the form
Open-market sales · 13,110 sh · avg $43.05 · $564,410
Loading xslF345X06/wk-form4_1788566051.xml…